Largest increase seen in women aged 25 to 34 years
NCD mortality declined in all high-income Western countries, with largest decline for both sexes in Denmark and smallest in U.S.
People who died of overdoses involving stimulants and no opioids were older, more often had history of CVD
Significant increase seen in crude nitrous oxide poisoning rate from 2010 to 2018, but no increase seen from 2019 to 2023
Opioids are most often the drug class implicated in causing death
Benefits include lower risk for death and cardiovascular disease, diabetes, dementia, and depression
Relatives of bereaved in high grief trajectory have increased use of mental health services, antidepressants, sedatives, and anxiolytics
Monthly DOD rate declined by −0.36 per 100,000 from August 2023 to February 2024, accelerating through October 2024
Findings seen for both suicide and overall mortality, with even stronger effects seen in more recent studies
Increased mortality seen in association with longer nap duration, greater intraindividual variability, more naps from 11 a.m. to 1 p.m., 1 to 3 p.m.